| abstract |
Disclosed is a novel hydroxyquinoxalinecarboxamide derivative which is useful for prevention and/or treatment of blood coagulation disorders. Specifically disclosed is a compound represent by formula (i) or a pharmacologically acceptable salt thereof. (i) (In the formula, R1 and R2 independently represent a hydrogen atom, a halogen atom or the like; R3 represents a hydrogen atom or the like; R4 and R5 independently represent a hydrogen atom, a halogen atom, a C1-4 alkyl group or the like; R6 and R7 independently represent a hydrogen atom or a C1-4 alkyl group; X represents a C3-10 cycloalkyl group, C6-10 aryl group or 5-10 membered heterocyclic group, which may be substituted by a member selected from the substituent group a, or the like; Y represents -CO-, -O-, -NRa- or the like; and Ra represents a hydrogen atom, a C1-4 alkyl group or the like.) |